AAAAAA
Results: 26-50/265
Citation: 3D conformal radiotherapy: pretreatment nomogram, PROSTATE C, 4(1), 2001, pp. 4-4
Citation: TUVP vs TURF: 3-year outcome, PROSTATE C, 4(1), 2001, pp. 4-4
Authors:
Kirby, R
Moul, J
Brawer, M
Citation: R. Kirby et al., BAUS Section of Oncology and the British Prostate Group Joint Meeting - Prostate Cancer Searching for the Horizon - Wednesday 15-Friday 17 November 2000 Celtic Manor Hotel, Newport, Wales, PROSTATE C, 4(1), 2001, pp. 5-5
Authors:
Brawer, MK
Citation: Mk. Brawer, Treatment of clinically localized prostatic carcinoma: helping our patients make an informed decision, PROSTATE C, 4(1), 2001, pp. 6-7
Citation: BAUS Section of Oncology and the British Prostate Group Joint Meeting - Prostate Cancer Searching for the Horizon - Wednesday 15-Friday 17 November 2000 Celtic Manor Hotel, Newport, Wales - Abstracts, PROSTATE C, 4(1), 2001, pp. 9
Authors:
Meng, MV
Carroll, PR
Citation: Mv. Meng et Pr. Carroll, Local therapy for prostate-specific antigen recurrence after definitive treatment, PROSTATE C, 4(1), 2001, pp. 20-27
Authors:
McEleny, KR
Watson, RWG
Fitzpatrick, JM
Citation: Kr. Mceleny et al., Defining a role for the inhibitors of apoptosis proteins in prostate cancer, PROSTATE C, 4(1), 2001, pp. 28-32
Authors:
Sepp-Lorenzino, L
Tjaden, G
Moasser, MM
Timaul, N
Ma, Z
Kohl, NE
Gibbs, JB
Oliff, A
Rosen, N
Scher, HI
Citation: L. Sepp-lorenzino et al., Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer, PROSTATE C, 4(1), 2001, pp. 33-43
Authors:
Nasu, Y
Bangma, CH
Hull, GW
Yang, G
Wang, J
Shimura, S
McCurdy, MA
Ebara, S
Lee, HM
Timme, TL
Thompson, TC
Citation: Y. Nasu et al., Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer, PROSTATE C, 4(1), 2001, pp. 44-55
Authors:
Beerlage, HP
Aarnink, RG
Ruijter, ET
Witjes, JA
Wijkstra, H
van de Kaa, CA
Debruyne, FMJ
de la Rosette, JJMCH
Citation: Hp. Beerlage et al., Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen, PROSTATE C, 4(1), 2001, pp. 56-62
Authors:
Maatman, TJ
Papp, SR
Carothers, GG
Shockley, KF
Citation: Tj. Maatman et al., The critical role of patient follow-up after receiving a diagnosis of prostatic intraepithelial neoplasia, PROSTATE C, 4(1), 2001, pp. 63-66
Authors:
Belldegrun, A
Citation: A. Belldegrun, What's hot in the prostate?, PROSTATE C, 3(4), 2000, pp. 213-216
Authors:
Kirby, R
Moul, J
Brawer, M
Citation: R. Kirby et al., 4th Biennial Prostate Cancer Think Tank Meeting - In Association with the United States Department of Defense Center for Prostate Disease Research - Hyatt Regency - Bethesda - USA - 10-12 March 2000., PROSTATE C, 3(4), 2000, pp. 217-217
Authors:
Bodmer, WF
Citation: Wf. Bodmer, Prostate cancer 2000, PROSTATE C, 3(4), 2000, pp. 218-223
Authors:
Greenberg, NM
Citation: Nm. Greenberg, Androgens and growth factors in prostate cancer: a transgenic perspective, PROSTATE C, 3(4), 2000, pp. 224-228
Authors:
Rhim, JS
Citation: Js. Rhim, In vitro human cell culture models for the study of prostate cancer, PROSTATE C, 3(4), 2000, pp. 229-235
Authors:
Neuhausen, SL
Citation: Sl. Neuhausen, The role of candidate genetic polymorphisms in the etiology of prostate cancer, PROSTATE C, 3(4), 2000, pp. 236-240
Authors:
Singh, R
Eeles, RA
Durocher, F
Simard, J
Edwards, S
Badzioch, M
Kote-Jarai, Z
Teare, D
Ford, D
Dearnaley, D
Ardern-Jones, A
Murkin, A
Dowe, A
Shearer, R
Kelly, J
Labrie, F
Easton, D
Narod, SA
Tonin, PN
Foulkes, WD
Citation: R. Singh et al., High risk genes predisposing to prostate cancer development - do they exist?, PROSTATE C, 3(4), 2000, pp. 241-247
Authors:
Moul, JW
Citation: Jw. Moul, Targeted screening for prostate cancer in African-American men, PROSTATE C, 3(4), 2000, pp. 248-255
Authors:
Kooiman, GG
Martin, FL
Williams, JA
Grover, PL
Phillips, DH
Muir, GH
Citation: Gg. Kooiman et al., The influence of dietary and environmental factors on prostate cancer risk, PROSTATE C, 3(4), 2000, pp. 256-258
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Schultz, D
Silver, B
Henry, L
Hurwitz, M
Kaplan, I
Beard, CJ
Tomaszewski, JE
Renshaw, AA
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer, PROSTATE C, 3(4), 2000, pp. 259-264
Authors:
Adolfsson, J
Steineck, G
Citation: J. Adolfsson et G. Steineck, Prognostic and treatment predictive factors - is there a difference?, PROSTATE C, 3(4), 2000, pp. 265-268
Authors:
Egawa, S
Arai, Y
Tobisu, K
Kuwao, S
Kamoto, T
Kakehi, Y
Baba, S
Citation: S. Egawa et al., Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy, PROSTATE C, 3(4), 2000, pp. 269-274
Authors:
Devens, BH
Weeks, RS
Burns, MR
Carlson, CL
Brawer, MK
Citation: Bh. Devens et al., Polyamine depletion therapy in prostate cancer, PROSTATE C, 3(4), 2000, pp. 275-279
Authors:
Pantuck, AJ
Zismon, A
Tso, CL
Belldegrun, AS
Citation: Aj. Pantuck et al., Intermittent androgen deprivation therapy: schedule modifications based ona novel in vivo human xenograft model, PROSTATE C, 3(4), 2000, pp. 280-282